14 Hakitor Street
Haifa Bay
Haifa 2624761
Israel
972 4 847 5700
https://www.taro.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 1,554
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Uday V. Baldota | CEO & Director | N/A | N/A | 1970 |
Mr. William J. Coote | VP, CFO & Chief Accounting Officer | N/A | N/A | 1955 |
Mr. Itamar Karsenti | VP & Head of Operations | N/A | N/A | 1972 |
Mr. Avi Avramoff | VP and Head of R&D | N/A | N/A | 1965 |
Mr. Itzik Baruch | Vice President of Technical Services | N/A | N/A | 1963 |
Dr. Roman Kaplan | Vice President of Scientific and Technical Compliance Manager | N/A | N/A | 1947 |
Mr. Erik Zwicker J.D. | VP, General Counsel & Secretary | N/A | N/A | 1980 |
Mr. Ara Aprahamian | Vice President of Sales & Marketing | 616.14k | N/A | 1968 |
Ms. Michele Visosky | VP & Head of Human Resource | N/A | N/A | 1966 |
Mr. Jayesh Shah | Head of Procurement | N/A | N/A | 1956 |
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.
Taro Pharmaceutical Industries Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.